Just a few hours of yoga can greatly reduce stress
Ten years of research on yoga as a stress-reducing activity provides a clear answer: A little effort offers real health benefits.
Read More
Combination treatment for liver cancer significantly improves progression-free survival in global trial
Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC). This research, led by Josep M. Llovet, MD, Ph.D., Professor of Medicine (Liver Diseases) at the Icahn School of Medicine at Mount Sinai, tested a combination of treatments that could help patients live longer without their cancer getting worse.
QIAGEN liefert genomische Inhalte für britische Initiative zur Genomsequenzierung von 100.000 Neugeborenen
Redwood City, Kalifornien, und Venlo, Niederlande–(BUSINESS WIRE)–QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute eine Partnerschaft mit Genomics England bekannt gegeben, um die Durchführung der Generation Study zu unterstützen. Ziel dieser einzigartigen Initiative ist es, die Genome von 100.000 Neugeborenen in England zu sequenzieren. Damit sollen über 200 ausgewählte Erkrankungen frühzeitig erkannt und seltene Krankheiten schneller behandelt werden. Mithilfe seiner Clinical Kno
Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs
DURHAM, N.C. & SEATTLE–(BUSINESS WIRE)–Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and Hevolution Foundation. “It is deeply gratifying to have seen this platform and company evolve so far,” said Tune Co-Founder Dr. Charles Gersbach, whose research at Duke University formed the basis for Tune’s TEMPO epi-editing platform. “Tune has already achieved a global la
Nonadherence to cancer screening varies by screening type
Nonadherence to cancer screening varies by screening type and sex, according to a study published in JAMA Network Open.
BridgeBio Oncology Therapeutics (BBOT) Granted U.S. FDA Fast Track Designation for BBO-8520 for KRASG12C-Mutated Metastatic Non-Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT” or the “Company”), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BBO-8520, an investigational oral therapy for the treatment of adult patients with previously treated, KRASG12C-mutated metastatic non-small cell lung cancer (NSCLC). BBO-8520 is designed to i
Medicare rules may reduce prescription steering
Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies. However, these pharmacies appear less used in Medicare than in other market segments. These PBMs are part of integrated health care conglomerates that own insurance companies and pharmacies, which may create conflicts of interest.
Extended nirmatrelvir/ritonavir found to be beneficial for some with long COVID
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series published online Jan. 6 in Communications Medicine.
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires
SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California residents impacted by the wildfires devastating Los Angeles County. Starting today, Angelenos can use the code LA-GOODRX-CARE to be seen by a licensed medical provider on GoodRx Care for a variety of conditions. Hundreds of thousands of Californians have been impacted by the wildfires, which may p
Weight gain after breast cancer development tied to heart failure risk
For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart failure, according to a research letter published online Jan. 9 in JAMA Oncology.